JP6326877B2 - 粉体 - Google Patents
粉体 Download PDFInfo
- Publication number
- JP6326877B2 JP6326877B2 JP2014049790A JP2014049790A JP6326877B2 JP 6326877 B2 JP6326877 B2 JP 6326877B2 JP 2014049790 A JP2014049790 A JP 2014049790A JP 2014049790 A JP2014049790 A JP 2014049790A JP 6326877 B2 JP6326877 B2 JP 6326877B2
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- magnesium oxide
- powder
- mass
- tableting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims description 27
- 239000000395 magnesium oxide Substances 0.000 claims description 33
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 33
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 33
- 238000000748 compression moulding Methods 0.000 claims description 18
- 239000003826 tablet Substances 0.000 description 49
- 230000000052 comparative effect Effects 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 230000000694 effects Effects 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000007884 disintegrant Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011812 mixed powder Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000008697 Cannabis sativa Nutrition 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Preparation (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
Description
(1)酸化マグネシウムを粉体全体の10.0〜90.0質量%含有し、該酸化マグネシウムの1質量部に対してマシニンを0.050質量部以上配合したことを特徴とする圧縮成形用粉体。
(2)前記(1)の粉体を圧縮成形して得られる錠剤。
ステアリン酸マグネシウムを除く表1記載の成分を各配合比に従い40錠分をビニール袋で混合し、500μm(30M)の篩で篩過を行った。その後、ステアリン酸マグネシウムを添加し、再度篩過し、ビニール袋で混合して圧縮成形用の粉体を調製した。この粉体を簡易錠剤成形機(HANDTAB−200;市橋精機社製)もしくは圧縮成形性測定評価装置(TAB FLEX;岡田精工社製)で圧縮成形し、1錠質量400mg又は500mgの錠剤(素錠)を得た。
実施例1〜5並びに比較例1〜3について、打錠機より錠剤が排出される際の負荷(錠剤排出時抵抗)及び錠剤の外観について検討した。
なお、本検討においては錠剤排出時抵抗を酸化マグネシウムの付着性に由来すると考えて、圧縮成形(打錠)後の錠剤排出抵抗を打錠障害の指標とし、また、錠剤の外観評価は目視で行い、錠剤側面に黒ずみが認められない場合を「○」、錠剤側面に黒ずみが認められた場合を「×」と表記した。
結果を表1に示し、また、錠剤側面の様子を図1〜8に示す。
Claims (4)
- 酸化マグネシウムを粉体全体の10.0〜90.0質量%含有し、該酸化マグネシウムの1質量部に対してマシニンを0.050質量部以上配合したことを特徴とする圧縮成形用粉体。
- 酸化マグネシウムの1質量部に対してマシニンを0.500質量部以上配合したことを特徴とする請求項1に記載の圧縮成形用粉体。
- 酸化マグネシウムの1質量部に対してマシニンを1.248質量部以上配合したことを特徴とする請求項1に記載の圧縮成形用粉体。
- 請求項1〜3のいずれかに記載の粉体を圧縮成形して得られる錠剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014049790A JP6326877B2 (ja) | 2013-04-03 | 2014-03-13 | 粉体 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013077800 | 2013-04-03 | ||
JP2013077800 | 2013-04-03 | ||
JP2014049790A JP6326877B2 (ja) | 2013-04-03 | 2014-03-13 | 粉体 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014210764A JP2014210764A (ja) | 2014-11-13 |
JP6326877B2 true JP6326877B2 (ja) | 2018-05-23 |
Family
ID=51930807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014049790A Active JP6326877B2 (ja) | 2013-04-03 | 2014-03-13 | 粉体 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6326877B2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5983700B2 (ja) | 2013-12-09 | 2016-09-06 | 株式会社デンソー | 半導体装置およびその製造方法、複合成形体 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000001428A (ja) * | 1998-04-16 | 2000-01-07 | Nippon Shinyaku Co Ltd | 錠剤及び製造法 |
JP4015485B2 (ja) * | 2001-08-27 | 2007-11-28 | 協和化学工業株式会社 | 制酸・緩下用錠剤 |
JP2004352633A (ja) * | 2003-05-28 | 2004-12-16 | Kowa Co | 酸化マグネシウム錠剤 |
JP2006022060A (ja) * | 2004-07-09 | 2006-01-26 | Kyowa Chem Ind Co Ltd | 制酸・緩下用水分散液およびそのための錠剤 |
-
2014
- 2014-03-13 JP JP2014049790A patent/JP6326877B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2014210764A (ja) | 2014-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101943686B1 (ko) | 구강내 붕괴정 및 그 제조 방법 | |
US20150238426A1 (en) | Granular material for orally fast disintegrating tablets | |
JP6133445B2 (ja) | 口腔内速崩壊性固形製剤用組成物 | |
KR101479824B1 (ko) | 용출 안정성 제제 | |
EP3177290B1 (en) | Pharmaceutical compositions of edoxaban | |
JP5286662B2 (ja) | 安中散含有錠剤 | |
JP6623753B2 (ja) | 炭酸ランタンを含む口腔内崩壊錠 | |
JP6496084B2 (ja) | 口腔内崩壊錠 | |
JP6326877B2 (ja) | 粉体 | |
WO2017170763A1 (ja) | 崩壊錠及びその製造方法 | |
TWI637749B (zh) | 以二階段濕式造粒步驟製造之崩解性粒子組成物及含有該組成物之口腔內崩解錠劑 | |
JP5490691B2 (ja) | 炭酸カルシウム含有速崩壊性製剤 | |
JP6341196B2 (ja) | 固形製剤 | |
JP2002012540A (ja) | 水易溶性薬物含有錠剤 | |
JP5680607B2 (ja) | 安定固形製剤及びその製造法 | |
JP5160156B2 (ja) | 栄養機能食品錠剤 | |
JP2004352633A (ja) | 酸化マグネシウム錠剤 | |
JP5710301B2 (ja) | 口腔内崩壊型錠及びその製造方法 | |
JP6037687B2 (ja) | グリメピリドを含有する口腔内崩壊錠 | |
JP5843986B2 (ja) | 粒状医薬組成物 | |
JP6004882B2 (ja) | 圧縮成形に用いるためのマンニトール賦形剤及びこれを含有する錠剤 | |
JP6235924B2 (ja) | フェノフィブラートの固体分散体 | |
WO2020122241A1 (ja) | 医薬組成物及びその製造方法 | |
JP5502358B2 (ja) | 口腔内速崩壊性錠剤およびその製造方法 | |
JP2017222728A (ja) | フェノフィブラートの固体分散体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170216 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20171114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180109 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180320 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180402 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6326877 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |